Kleiburg, F. https://orcid.org/0000-0003-4757-8777
van der Hulle, T.
Gelderblom, H.
Slingerland, M.
Speetjens, F. M.
Hawinkels, L. J.A.C.
Dibbets-Schneider, P.
van Velden, F. H.P.
Pool, M.
Lam, S. W.
Bovée, J. V.M.G.
Heijmen, L.
de Geus-Oei, L. F.
Funding for this research was provided by:
This research was funded by the Top consortium for Knowledge and Innovation (TKI) and Philips Healthcare through a PPP allowance (This research was funded by the Top consortium for Knowledge and Innovation (TKI) and Philips Healthcare through a PPP allowance)
Article History
Received: 28 January 2025
Accepted: 15 March 2025
First Online: 27 March 2025
Declaration
:
: The authors declare no conflict of interest.
: This study was conducted according to the guidelines of the Declaration of Helsinki, and in accordance with the Medical Research Involving Human Subjects Act. The study was approved by the Medical Ethics Committee Leiden The Hague Delft (reference number NL78279.058.21, registration number P22.001). The trial is registered on clinicaltrials.gov as NCT05522257.
: All patients have provided written informed consent.
: Not applicable.